Sofosbuvir plus ribavirin for the treatment of hepatitis C virus genotype 2 in Korea: What's the optimal dosage of ribavirin in real-world setting? [electronic resource]
Producer: 20190424Description: 31-37 p. digitalISSN:- 1751-2980
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antiviral Agents -- adverse effects
- Dose-Response Relationship, Drug
- Drug Therapy, Combination
- Female
- Genotype
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- complications
- Humans
- Male
- Middle Aged
- Republic of Korea
- Retrospective Studies
- Ribavirin -- adverse effects
- Sofosbuvir -- adverse effects
- Sustained Virologic Response
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.